Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × abemaciclib × Thoracic × Clear all

Phase

Phase 2 4 Phase 1 4 Phase 1/2 2 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 19 Thoracic 1 Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 232 Cisplatin 185 Pemetrexed 158 Paclitaxel 120 Docetaxel 108 pembrolizumab 88 Gemcitabine 72 Etoposide 52 Erlotinib Hydrochloride 51 Radiotherapy 47 durvalumab 41 Vinorelbine 37 Bevacizumab 37 atezolizumab 35 Nivolumab 33 Gefitinib 31 Drug Therapy 30 osimertinib 24 Topotecan 23 130-nm albumin-bound paclitaxel 19 Radiosurgery 18 tislelizumab 17 Ipilimumab 15 Crizotinib 15 Albumin-Bound Paclitaxel 13 aumolertinib 12 Platinum 12 Dexamethasone 12 Surgical Procedures, Operative 11 Injections 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02152631 2026-02-06

JUNIPER

Eli Lilly and Company

Phase 3 Active not recruiting

453 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡